Zobrazeno 1 - 10
of 45
pro vyhledávání: '"I. Cañamares-Orbis"'
Autor:
EA Álvaro Alonso, N Barrueco Fernandez, C Esteban Alba, I Cañamares Orbis, S Prieto Roman, L Pedraza Nieto, A Such Diaz, E Izquierdo García, P Tejedor Prado, A Aguilar Ros, I Escobar Rodriguez
Publikováno v:
Late breaking abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8df597198f0d996b91e2318b0b606e9c
https://doi.org/10.1136/ejhpharm-2023-eahp.364
https://doi.org/10.1136/ejhpharm-2023-eahp.364
Autor:
C. García-Muñoz, S. Cortijo-Cascajares, I. Cañamares-Orbis, M. P. Goyache-Goñi, J. M. Ferrari-Piquero
Publikováno v:
Farmacia Hospitalaria, Vol 38, Iss 2, Pp 130-134 (2014)
Abstract: Objective: To describe the outcomes produced by concomitant use of HER2-receptor inhibitors Lapatinib and Trastuzumab for the treatment of HER 2-positive metastatic breast cancer. Method: Retrospective observational study. Patients treate
Externí odkaz:
https://doaj.org/article/8c7d7767bc104650b09d691dbf677340
Autor:
E Palencia Herrejon, P Tejedor Prado, JL Fraile González, B Sánchez Artola, I Cañamares Orbis, A Such Díaz, L Cano Alcalde, J Garrido Dorronsoro, E Izquierdo García, I. Escobar Rodríguez, A Lázaro Cebas
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance Hospital at home (HaH) units provide hospital level care at home to patients who would otherwise remain hospitalised. This hospitalisation model is growing as it saves costs, reducing hospital stay and complications such as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2915fe9aaada82b8fd09710ba316880
https://doi.org/10.1136/ejhpharm-2021-eahpconf.257
https://doi.org/10.1136/ejhpharm-2021-eahpconf.257
Autor:
I. Cañamares Orbis, C. García Muñoz, B. Calderón Hernanz, S. Cortijo Cascajares, J.M. Ferrari Piquero
Publikováno v:
Pharmaceutical Care España, Vol 15, Iss 6 (2013)
Externí odkaz:
https://doaj.org/article/3787a2d7ea234b03ab6cf23ab7ce5d2b
Autor:
F. Apolo Carvajal, I Cañamares Orbis, M. González Martínez, B Caliz Hernandez, H Hernandez Ovejero, MT Llanos Garcia, A. Escudero Brocal, A Aranguren Oyarzábal, I Mayorga Bajo, E Capilla Santamaría, N Martinez Casanova
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance The occupational risk due to exposure to hazardous drugs (HDs) has been a mounting concern to healthcare professionals, including in nursing homes. Aim and objectives To study the impact of a strategy to improve safe handlin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba73f2055311bd74beeba53360568a01
https://doi.org/10.1136/ejhpharm-2020-eahpconf.265
https://doi.org/10.1136/ejhpharm-2020-eahpconf.265
Autor:
I. Escobar Rodríguez, E Izquierdo García, S Esteban-Casado, I Cañamares Orbis, A Lázaro Cebas, EA Álvaro Alonso, P Tejedor Prado, A Such Díaz, C. Esteban Alba, A. Santiago Pérez
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Over the past 10 years, a pharmacotherapy revolution in the treatment of moderate to severe plaque psoriasis (MS-PP) has occurred. In our country, the prescription of ustekinumab has increased greatly since its approval in 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4b3aea401d556ae420bc1c217e05e62
https://doi.org/10.1136/ejhpharm-2020-eahpconf.217
https://doi.org/10.1136/ejhpharm-2020-eahpconf.217
Autor:
A Lázaro Cebas, I Cañamares Orbis, P Tejedor Prado, A Such Díaz, FJ Rupérez Pascualena, I. Escobar Rodríguez, MP Lorenzo García, A Aguilar Ros, EA Álvaro Alonso, S Esteban Casado
Publikováno v:
Section 3: Production and Compounding.
Background and importance On the basis of resolution 189/2018 published by our city health council, the hospital pharmacy service was entrusted with the centralisation of the procedure for the acquisition, compounding, distribution and dispensing of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9963ddf791d2677591adf89042e17f45
https://doi.org/10.1136/ejhpharm-2020-eahpconf.77
https://doi.org/10.1136/ejhpharm-2020-eahpconf.77
Autor:
S Esteban Casado, I Cañamares Orbis, A Lázaro Cebas, P Tejedor Prado, A. Santiago Pérez, C. Esteban Alba, I. Escobar Rodríguez, A Such Díaz, EA Álvaro Alonso, E Izquierdo García
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance After the National Institute for Occupational Safety and Health (NIOSH) classified hazardous drugs (HD), it was deemed necessary to make healthcare workers aware of the risks associated with handling HD in their daily work t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c47aa8ca0d772ec8ac22e61dd3bc420
https://doi.org/10.1136/ejhpharm-2020-eahpconf.433
https://doi.org/10.1136/ejhpharm-2020-eahpconf.433
Publikováno v:
Farmacia Hospitalaria, Vol 38, Iss 4, Pp 379-380 (2014)
The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is an affectation that causes hyponatremia among other symptoms. Currently the family of drugs of choice for this syndrome are vaptans, among them the tolvaptan, antagonists of v
Externí odkaz:
https://doaj.org/article/4c0fd6c1412744198eb70e0f5a21d2e7
Autor:
A Lázaro Cebas, A Such Díaz, E Izquierdo García, P Tejedor Prado, EA Álvaro Alonso, S Esteban Casado, I. Escobar Rodríguez, I Cañamares Orbis, A. Santiago Pérez, C. Esteban Alba
Publikováno v:
Section 3: Production and Compounding.
Background The National Institute for Occupational Safety and Health (NIOSH) has studied only the hazards of marketed drugs, excluding raw materials (RM). For this reason, it is necessary to study the hazards of RM used in the compounding of pharmace
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c29e9367704772a0d38d8da726e0ed89
https://doi.org/10.1136/ejhpharm-2019-eahpconf.121
https://doi.org/10.1136/ejhpharm-2019-eahpconf.121